PATENT CLAIM ANALYSIS

Application Number: 15887239
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["600", "365000"]

Abstract:
Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when biomarker sampling parameters fall within the target biomarker range.

Claim (Index 1):
A testing method suitable for a diabetic person to optimize an administered insulin dosage comprising:\n providing a structured collection procedure from a server of a health care provider to a collection device configured to guide the diabetic person through the structured collection procedure and optimize the administered insulin dosage, wherein the collection device comprises a meter configured to measure one or more selected biomarkers, a processor disposed inside the meter and coupled to a memory, wherein the memory stores the structured collection procedure provided from the server, and software having instructions that when executed by the processor causes the processor to instruct the diabetic person to collect one or more sampling sets of biomarker data in accordance with the structured collection procedure, wherein the server is a central repository for a plurality of the structured collection procedures; executing the software on the collection device and according to instructions and timing provided by the structured collection procedure: collecting one or more sampling sets of biomarker data, wherein each of the one or more sampling sets comprises a plurality of sampling instances recorded over a collection period and each sampling instance of the plurality of sampling instances comprises an acceptable biomarker reading recorded upon compliance with one or more acceptance criterion based on at least one of a schedule-based action or a patient-based action and that is applied to the one or more sampling sets of biomarker data; wherein after each collection of the one or more sampling sets of biomarker data, said processor performs the processes of: determining a biomarker sampling parameter from the one or more sampling sets of biomarker data whereby only these biomarker data are considered which are in compliance with the one or more acceptance criterion; comparing the biomarker sampling parameter to a target biomarker range; calculating an insulin adjustment parameter associated with the biomarker sampling parameter in response to the biomarker sampling parameter falling outside the target biomarker range; adjusting an insulin dosage by an amount of the insulin adjustment parameter in response to the biomarker sampling parameter falling outside the target biomarker range and in response to the insulin dosage not exceeding maximum dosage; and exiting the testing method in response to the adjusted insulin dosage being optimized as an optimized insulin dosage such that the optimized insulin dosage is administered as the administered insulin dosage, otherwise repeating with a next sampling set of the one or more sampling sets of biomarker data, the optimized insulin dosage being achieved when the one or more biomarker sampling parameters fall within the target biomarker range.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 2.18056
- Patent Class: 600.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12818795', '13107436', '13107467', '14469221', '12643338']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4584820709933584
- 35 USC 102 Novelty (BERT): 0.5290016691149004
- Combined Prediction Score: 0.4655340308055126
- Mean Citation Score: 294.67090599999995
- Max Citation Score: 368.70926
- Similarity Product: 327.449934956423

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test